CereVasc's eShunt® System Study Data Presented at the ABC WIN Seminar
/PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from its...
Stay updated with breaking news from Adel Malek. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from its...
/PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that data from...
/PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced that the U.S. Food...
CereVasc announced today that the FDA approved an investigational device exemption (IDE) supplement for a study of its eShunt system.
July 7, 2023—CereVasc, Inc. and LianMedical recently announced a partnership focused on bringing CereVasc’s eShunt system and related prod